1. Home
  2. Labeler Index
  3. Hf Acquisition Co Llc, Dba Healthfirst
  4. 51662-1418
  5. NDC Package Code: 51662-1418-1 Nalbuphine Hci

NDC Package 51662-1418-1 Nalbuphine Hci

Injection, Solution Intramuscular; Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51662-1418-1
Package Description:
1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE
Product Code:
51662-1418
Proprietary Name:
Nalbuphine Hci
Non-Proprietary Name:
Nalbuphine Hci
Substance Name:
Nalbuphine Hydrochloride
Usage Information:
Nalbuphine Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Nalbuphine Hydrochloride Injection can also be used as a supplement to balanced anesthesia, for preoperative and postoperative analgesia, and for obstetrical analgesia during labor and delivery.Limitations of UseBecause of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS], reserve Nalbuphine Hydrochloride Injection for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] Have not been tolerated, or are not expected to be tolerated Have not provided adequate analgesia, or are not expected to provide adequate analgesia
11-Digit NDC Billing Format:
51662141801
NDC to RxNorm Crosswalk:
  • RxCUI: 904440 - nalbuphine HCl 20 MG/ML Injectable Solution
  • RxCUI: 904440 - nalbuphine hydrochloride 20 MG/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hf Acquisition Co Llc, Dba Healthfirst
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • NALBUPHINE HYDROCHLORIDE 20 mg/mL
    • Pharmacologic Class(es):
  • Competitive Opioid Antagonists - [MoA] (Mechanism of Action)
  • Opioid Agonist/Antagonist - [EPC] (Established Pharmacologic Class)
  • Partial Opioid Agonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA070918
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-29-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 51662-1418-1 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    51662141801J2300Inj nalbuphine hydrochloride10 MG1012020

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51662-1418-1?

    The NDC Packaged Code 51662-1418-1 is assigned to a package of 1 vial, multi-dose in 1 carton / 10 ml in 1 vial, multi-dose of Nalbuphine Hci, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. The product's dosage form is injection, solution and is administered via intramuscular; intravenous; subcutaneous form.

    Is NDC 51662-1418 included in the NDC Directory?

    Yes, Nalbuphine Hci with product code 51662-1418 is active and included in the NDC Directory. The product was first marketed by Hf Acquisition Co Llc, Dba Healthfirst on October 29, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51662-1418-1?

    The 11-digit format is 51662141801. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151662-1418-15-4-251662-1418-01